Douglas Conrad
- Biochemistry top 1%
-
- Cystic Fibrosis Research Advances 39
- Neonatal Respiratory Health Research 12
- Inhalation and Respiratory Drug Delivery 11
- Tracheal and airway disorders 7
- Chronic Obstructive Pulmonary Disease (COPD) Research 7
- Immunology top 5%
- Molecular Medicine top 5%
- Molecular Biology top 5%
- Gut microbiota and health 9
- Bacterial biofilms and quorum sensing 5
-
- Asthma and respiratory diseases 8
- Co-authors
- Forest RohwerYan Wei LimElliott SigalRobert SchmiederMike FurlanColin FunkJohn S. WelchChristoph J. Binder
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Douglas Conrad
69 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Biochemistry 311
- Pulmonary and Respiratory Medicine 1.2k
- Immunology 655
- Molecular Medicine 138
- Molecular Biology 1.9k
Countries citing papers authored by Douglas Conrad
This map shows the geographic impact of Douglas Conrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Conrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Conrad more than expected).
Fields of papers citing papers by Douglas Conrad
This network shows the impact of papers produced by Douglas Conrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Conrad. The network helps show where Douglas Conrad may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Douglas Conrad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 42 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 17 | |
| 12 | 2020 | 7 | |
| 13 | 2017 | 15 | |
| 14 | 2017 | 11 | |
| 15 | 2015 | 18 | |
| 16 | 2012 | 76 | |
| 17 | 2011 | 118 | |
| 18 | 2010 | 18 | |
| 19 | 1999 | 1 | |
| 20 | 1978 | 2 |
About Douglas Conrad
Douglas Conrad is a scholar working on Pulmonary and Respiratory Medicine, Space and Planetary Science, Endocrinology, Critical Care and Intensive Care Medicine and Emergency Medical Services, having authored 71 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (39 papers), Neonatal Respiratory Health Research (12 papers), Inhalation and Respiratory Drug Delivery (11 papers), Gut microbiota and health (9 papers), Asthma and respiratory diseases (8 papers), Tracheal and airway disorders (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Bacterial biofilms and quorum sensing (5 papers). The work is most often cited by research in Biochemistry (311 citations), Pulmonary and Respiratory Medicine (1.2k citations), Immunology (655 citations), Molecular Medicine (138 citations) and Molecular Biology (1.9k citations). Douglas Conrad has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Forest Rohwer, Yan Wei Lim, Elliott Sigal, Robert Schmieder, Mike Furlan, Colin Funk, John S. Welch, Christoph J. Binder, Timothy M. Willson and Joseph L. Witztum. Their work appears in journals such as Journal of Cystic Fibrosis, PLoS ONE, The ISME Journal, American Journal of Respiratory and Critical Care Medicine and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.